SCHEMBL599891

SCHEMBL599891

CC(=O)OCCCCCCCCOc1cc[nH]c(=S)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.39
MMP2 P08253 2/20 0.36
ALDH1A1 P00352 1/20 0.35
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
P2RY12 Q9H244 1/20 0.34
GAA P10253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP12 P39900 1/20 0.33
NEK1 Q96PY6 1/20 0.33
GRM2 Q14416 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TNKS2 Q9H2K2 1/20 0.32
POLB P06746 1/20 0.32
APEX1 P27695 1/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
RAD52 P43351 1/20 0.32
NUDT1 P36639 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL602915 0.84 PTGS2 (0.39) PTGS2ALDH1A1PDE3BPDE3AP2RY12
SCHEMBL600516 0.79 PTGS2 (0.52) PTGS2MMP2ALDH1A1HTTLMNA
SCHEMBL4740615 0.72 MEN1 (0.53) PTGS2ALDH1A1GAAL3MBTL1HTT
SCHEMBL600143 0.71 ALDH1A1 (0.34) ALDH1A1L3MBTL1POLBTDP1LMNA
SCHEMBL24087412 0.70 LMNA (0.51) PTGS2ALDH1A1L3MBTL1POLBTDP1
SCHEMBL11946222 0.69 PTGS2 (0.52) PTGS2ALDH1A1L3MBTL1POLBTDP1
SCHEMBL12853267 0.67 LMNA (0.53) PTGS2ALDH1A1GAAL3MBTL1POLB
SCHEMBL5136503 0.67 ALDH1A1 (0.70) PTGS2ALDH1A1GAALMNASMN1; SMN2
SCHEMBL11492305 0.67 ALDH1A1 (0.70) PTGS2ALDH1A1GAALMNASMN1; SMN2
SCHEMBL15299079 0.67 ALDH1A1 (0.70) PTGS2ALDH1A1GAALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2420500-A1 PYRIDINE THIO DERIVATIVE, AND PHARMACEUTICAL COMPOSITION WHICH CONTAINS SAME AND HAS ANTI-HELICOBACTER PYLORI ACTION aRigen Pharmaceuticals, Inc. (JP) 2012-02-22 EP disclosed
US-20120041030-A1 PYRIDINE THIO DERIVATIVE, AND PHARMACEUTICAL COMPOSITION WHICH CONTAINS SAME AND HAS ANTI-HELICOBACTER PYLORI ACTION LINK GENOMICS, INC. (JP) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041030-A1 PYRIDINE THIO DERIVATIVE, AND PHARMACEUTICAL COMPOSITION WHICH CONTAINS SAME AND HAS ANTI-HELICOBACTER PYLORI ACTION TPMT, TST, PTPN11 PTGS2 347/4885MMP2 4697/4885ALDH1A1 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.